NYMOX PHARMACEUTICAL CORPORATION Current Accrued Expenses And Other Current Liabilities
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) had Current Accrued Expenses And Other Current Liabilities of $4.14 million as of 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Notes
ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities · last filed 2025-06-03
- 2024-12-31: Current Accrued Expenses And Other Current Liabilities $4.14M.
- 2024-09-30: Current Accrued Expenses And Other Current Liabilities $4.31M.
- 2023-12-31: Current Accrued Expenses And Other Current Liabilities $3.05M.
- 2023-09-30: Current Accrued Expenses And Other Current Liabilities $2.56M.
| Period end | Current Accrued Expenses And Other Current Liabilities | Current Accrued Expenses And Other Current Liabilities as first filed |
|---|---|---|
| 2024-12-31 | $4.14M 20-F · filed 2025-06-03 | |
| 2024-09-30 | $4.31M 6-K · filed 2025-01-02 | |
| 2023-12-31 | $3.05M 20-F · filed 2025-06-03 | |
| 2023-09-30 | $2.56M 6-K · filed 2023-11-15 | |
| 2023-06-30 | $2.34M 6-K · filed 2023-08-14 | |
| 2023-03-31 | $2.26M 6-K · filed 2023-05-12 | |
| 2022-12-31 | $1.93M 20-F · filed 2024-08-29 | $5.00K 20-F · filed 2023-05-02 |
| 2022-09-30 | $2.14M 6-K/A · filed 2022-11-16 | |
| 2022-06-30 | $1.96M 6-K · filed 2022-08-15 | |
| 2021-12-31 | $23.00K 20-F · filed 2023-05-02 | |
| 2020-12-31 | $74.00K 20-F · filed 2023-05-02 | |
| 2019-12-31 | $40.00K 20-F · filed 2022-03-30 | |
| 2018-12-31 | $50.00K 20-F · filed 2021-03-29 | |
| 2016-12-31 | $14.00K 20-F · filed 2019-03-29 | |
| 2015-12-31 | $202.00K 20-F · filed 2018-03-30 |